Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-31

Clinical Trial Update: Multihance at 3 Tesla (3T) in Brain Tumors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Multihance at 3 Tesla in brain tumors completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MULTIHANCE (Gadobenate dimeglumine)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Brain Tumor | Phase 4 | Status: COMPLETED | Results posted: 2009-07-31